QGO FINANCE LIMITED (QGO.BO)
INR 55.7
(0.0%)
INR 55.7
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -591.53 Thousand | 16.15 Million | 8.14 Million | -1.55 Million | 3.18 Million | -36.09 Million |
| Net Income | 26.53 Million | 17.59 Million | 13.03 Million | 6.41 Million | 5.82 Million | 409.1 Thousand |
| Depreciation & Amortization | 2.08 Million | 2.08 Million | 869.52 Thousand | 270.71 Thousand | 300.6 Thousand | 113.43 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -137.23 Million | -3.84 Million | -6.34 Million | -10.99 Million | -5.14 Million | -42.33 Million |
| Other non-cash items | 108.01 Million | -123.76 Million | -223.47 Million | -131.08 Million | -114.08 Million | -72.39 Million |
| Investing Cash Flow | -943.56 Thousand | -2.02 Million | -3.52 Million | -397.07 Thousand | -202.77 Thousand | -958.5 Thousand |
| Investments in PPE | -943.56 Thousand | -2.04 Million | -3.52 Million | -397.07 Thousand | -202.77 Thousand | -958.5 Thousand |
| Acquisitions | - | 18 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 18 Thousand | - | - | - | - |
| Financing Cash Flow | -3.47 Million | -2.78 Million | -1.39 Million | - | - | 36 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -3.47 Million | -2.78 Million | -1.39 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 36 Million |
| Other Financing Activities | - | - | - | - | - | 36 Million |
| Accounts receivables | -10.07 Million | -4.48 Million | -8.71 Million | - | - | - |
| Accounts payables | 107.69 Million | 132.72 Million | 234.51 Million | 134.38 Million | 116.89 Million | 78.35 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -137.23 Million | -132.08 Million | -232.14 Million | -145.37 Million | -122.03 Million | -120.69 Million |
| Cash at beginning of period | 15.96 Million | 4.61 Million | 1.19 Million | 3.33 Million | 159.43 Thousand | 1.4 Million |
| Cash at end of period | 10.95 Million | 15.96 Million | 4.61 Million | 1.19 Million | 3.33 Million | 159.43 Thousand |
| Capital Expenditure | -943.56 Thousand | -2.04 Million | -3.52 Million | -397.07 Thousand | -202.77 Thousand | -958.5 Thousand |
| Effect of forex changes on cash | - | 1.00 | - | - | - | 2985.00 |
| Net cash flow / Change in cash | -5.01 Million | 11.35 Million | 3.42 Million | -2.13 Million | 3.17 Million | -1.24 Million |
| Free Cash Flow | -1.53 Million | 14.11 Million | 4.61 Million | -1.94 Million | 2.98 Million | -37.04 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 8.73 Million | 8.75 Million | 26.53 Million | 6.87 Million | 5.82 Million | 5.09 Million |
| Depreciation & Amortization | 273 Thousand | 1.44 Million | 2.08 Million | 202 Thousand | 224 Thousand | 223 Thousand |
| Deferred income taxes | - | - | - | 189 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -54.86 Million | -5.2 Million | -29.53 Million | -7.9 Million | - | - |
| Other non-cash items | 42.12 Million | -20.49 Million | -93.12 Million | -9.82 Million | -5.82 Million | -5.09 Million |
| Investing Cash Flow | -3.74 Million | -518.56 Thousand | -943.56 Thousand | - | - | - |
| Investments in PPE | -3.74 Million | -518.56 Thousand | -943.56 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -1.04 Million | -1.04 Million | -3.47 Million | -1.04 Million | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -1.04 Million | -1.04 Million | -3.47 Million | -1.04 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -4.31 Million | -7.38 Million | -10.07 Million | 166 Thousand | - | - |
| Accounts payables | 42 Million | 30.83 Million | 107.69 Million | 10.1 Million | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -54.86 Million | -28.65 Million | -127.15 Million | -18.17 Million | - | - |
| Cash at beginning of period | 10.95 Million | 7.49 Million | 15.96 Million | 9.08 Million | 15.03 Million | 15.96 Million |
| Cash at end of period | 2.44 Million | 10.95 Million | 10.95 Million | 7.49 Million | 9.08 Million | 15.03 Million |
| Capital Expenditure | -3.74 Million | -518.56 Thousand | -943.56 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -8.51 Million | 3.46 Million | -5.01 Million | -1.58 Million | -5.95 Million | -930.78 Thousand |
| Free Cash Flow | -7.47 Million | 4.53 Million | -1.53 Million | -782.99 Thousand | 5.82 Million | 5.09 Million |
CITAY
4572
3079
NEX
MEDP
GCTS